Bicara Therapeutics Inc. Stock Performance
as on October 3, 2026 at 2:09 am IST
Day's Low
Day's High
$18.04$18.96
0.55%
Downside
4.52%
Upside
52 Week's Low
52 Week's High
$13.70$30.9924.48%
Downside
70.84%
Upside
Bicara Therapeutics Inc. share price movements today
- Previous Close
- $18.20
- Open
- $18.46
- Volume
- 137.2K
- Market Cap
- $1.2B
- Day's Low - High
- $18.04 - $18.96
- 52 Week Low - High
- $13.70 - $30.99
Bicara Therapeutics Inc. Historical Returns
- 1 Month Return
- -22.75 %
- 3 Month Return
- -37.24 %
- 1 Year Return
- + 8.92 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Bicara Therapeutics Inc. Stock Fundamentals & Key Indicators
Check Bicara Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-3.1
Dividend Yield
0.00%
PE Ratio (TTM)
-6
Industry PE ratio
-6.39
PEG Ratio
0.14
Return On Equity TTM
-41.49%
Bicara Therapeutics Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Bicara Therapeutics Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $1.2B | NA | -6.00 | 0.00% | 0.00% | |
| StrongBuy | $44.0B | 607.04% | -23.17 | 0.00% | 0.00% | |
| Neutral | $76.9B | -44.61% | -24.13 | -12.57% | 0.00% | |
| StrongBuy | $132.5B | 180.98% | 30.19 | 86.04% | 0.00% | |
| Buy | $77.3B | 28.74% | 18.11 | 84.86% | 0.49% |
Stock Returns calculator for Bicara Therapeutics Inc. Stock including INR - Dollar returns
The Bicara Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Bicara Therapeutics Inc. investment value today
Current value as on today
₹1,17,833
Returns
₹17,833
(+17.83%)
Returns from Bicara Therapeutics Inc. Stock
₹8,558 (+8.56%)
Dollar Impact
₹9,275 (+9.27%)
Analyst Recommendation on Bicara Therapeutics Inc. Stock
Based on 6 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for Bicara Therapeutics Inc.. Average target price of $34.3333333333333
Indian Investors' Interest in Bicara Therapeutics Inc. Stock
Search interest for Bicara Therapeutics Inc. Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Bicara Therapeutics Inc. Quarterly Profit & Loss
All numbers in Millions USD
Bicara Therapeutics Inc. Annual Profit & Loss
All numbers in Millions USD
Bicara Therapeutics Inc. Quarterly Cash Flow
All numbers in Millions USD
Bicara Therapeutics Inc. Annual Cash Flow
All numbers in Millions USD
Insights on Bicara Therapeutics Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 566.0% return, outperforming this stock by 557.1%
NEGATIVE IMPACTPrice Dip
In the last 1 month, BCAX stock has moved down by -22.8%
About Bicara Therapeutics Inc.
| Organisation | Bicara Therapeutics Inc. |
| Headquarters | 116 Huntington Avenue, Boston, MA, 02116, US |
| Industry | Biotechnology |
| CEO | Claire Mazumdar Clemon |
Key Management of Bicara Therapeutics Inc.
Name | Title |
|---|---|
Ms. Lara S. Meisner J.D. | Chief Legal Officer, Compliance Officer & Corporate Secretary |
Ms. Sathish Hasige Ph.D. | Senior VP and Head of Technical Operations & Supply Chain |
Dr. Jeltje Schulten M.B.A., M.D. | Senior Vice President of Clinical & Medical Affairs |
Dr. Claire Mazumdar Clemon M.B.A., Ph.D. | CEO & Director |
Ms. Rachel Frank | Vice President of Investor Relations and Corporate Communications |
Ms. Pauline Dufresne | Chief People Officer |
Ms. Rachel Salazar | SVP of R&D Strategy and Operations |
Ms. Angela Windt | VP & Head of Regulatory Affairs |
Mr. Ryan Cohlhepp Pharm.D. | President, COO & Director |
Ms. Jennifer Larson | CFO, Treasurer & Principal Accounting Officer |
FAQs
What is Bicara Therapeutics Inc. share price today?
Bicara Therapeutics Inc. share price today is $18.14 as on . Bicara Therapeutics Inc. share today touched a day high of $18.96 and a low of $18.04.
What is the 52 week high and 52 week low for Bicara Therapeutics Inc. share?
Bicara Therapeutics Inc. share touched a 52 week high of $30.99 on and a 52 week low of $13.70 on . Bicara Therapeutics Inc. stock price today i.e. is trending at $18.14,which is 41.46% down from its 52 week high and 32.41% up from its 52 week low.
What is Bicara Therapeutics Inc.'s market capitalisation today?
Bicara Therapeutics Inc. market capitalisation is $0.00T as on .
How to invest in Bicara Therapeutics Inc. Stock (BCAX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Bicara Therapeutics Inc. on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Bicara Therapeutics Inc. Stock (BCAX) from India?
Indian investors can start investing in Bicara Therapeutics Inc. (BCAX) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Bicara Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bicara Therapeutics Inc. share’s latest price of $18.14 as on October 2, 2026 at 8:39 pm IST, you will get 0.5513 shares of Bicara Therapeutics Inc.. Learn more about
fractional shares .